InvestorsHub Logo
Followers 2
Posts 736
Boards Moderated 0
Alias Born 05/16/2017

Re: mynah post# 20219

Sunday, 05/26/2019 8:08:09 AM

Sunday, May 26, 2019 8:08:09 AM

Post# of 20617
mynah, of course it works. As an FDA approved generic and now an approved OTC medication, bioequivalance to Flonase needed to be proven. If Flonase works, our product does, too. Of course, there will be minor differences in the formulation and spray design.

While no one has any deeper knowledge of management's strategy I believe it's evident that they are trying to sell out their current batch before it expires Aug 2019. They also use competitive pricing to get FlutiCare in as many noses during allergy season as possible. Remember, we are late to the game and need to make up lost ground. Furthermore pricing has brought FlutiCare to the top rank right after Flonase in the fluticasone nasal spray category. It has garnered a very high number of reviews in only 18 months and is now perceived as a major fluticasone brand on Amazon.

In a sense, they sacrificed profits of the first batch to establish the brand.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.